EP Patent

EP0970945A1 — Radiation curable acrylic-acid esters containing hydroxyalkylamide groups

Assigned to Koninklijke DSM NV · Expires 2000-01-12 · 26y expired

What this patent protects

The invention relates to a radiation curable compound such as (I) which is a mono or multi valent carboxylic ester of a compound containing a hydroxyalkylamidegroup and a hydroxygroup in which the carboxylic ester is derived from an α,β-ethylenically unsaturated carboxylic acid. …

USPTO Abstract

The invention relates to a radiation curable compound such as (I) which is a mono or multi valent carboxylic ester of a compound containing a hydroxyalkylamidegroup and a hydroxygroup in which the carboxylic ester is derived from an α,β-ethylenically unsaturated carboxylic acid. A coating composition comprising this compound has a high rate of polymerisation and shows the desired chemical and mechanical properties.

Drugs covered by this patent

Patent Metadata

Patent number
EP0970945A1
Jurisdiction
EP
Classification
—
Expires
2000-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Koninklijke DSM NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.